Scientific World's Low Tolerance For Controversy

Among scientists, Joachim Messing, in his excellent commentary (The Scientist, June 27, 1994, page 13), made the case for supporting many small, rather than a few large, projects. Some excellent suggestions on improvements have also been proposed by Jose M. Musacchio, though he, too, refrains from suggesting major changes in the peer-review system (FASEB Journal, 8:679-83, 1994). Of all the information recently brought out on spons

Written byNaomi Kraus
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Among scientists, Joachim Messing, in his excellent commentary (The Scientist, June 27, 1994, page 13), made the case for supporting many small, rather than a few large, projects. Some excellent suggestions on improvements have also been proposed by Jose M. Musacchio, though he, too, refrains from suggesting major changes in the peer-review system (FASEB Journal, 8:679-83, 1994).

Of all the information recently brought out on sponsored research, one fact is truly alarming. This is the decrease in the number of young scientists who apply for grants. According to a new report by the National Research Council (NRC), applications for National Institutes of Health funding from researchers under 36 years of age declined about 55 percent between 1985 and 1993 (The Funding of Young Investigators in the Biological and Biomedical Sciences, Washington, D.C., National Academy Press, 1994). If this trend continues, it will lead to the decline, if not the extinction, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies